News

Sequana Medical Announces Sudden Passing of Founder, President & CEO

22 December 2016

Zurich, SWITZERLAND – 22 December 2016 -- The Board of Directors of Sequana Medical AG ("Sequana Medical" or the "Company") announces with great sadness, the sudden death of its Founder, President and Chief Executive Officer, Noel L. Johnson, Ph. D.

Read more

Ian Crosbie joins Sequana Medical as Chief Financial Officer

11 July 2016

Zurich, SWITZERLAND – 11 July 2016 – Sequana Medical AG, a privately held medical device company focused on the development and commercialization of innovative, implantable pump systems that manage fluid build-up occurring in patients with liver disease, heart disease and certain cancers, announced today the appointment of Ian Crosbie as Chief Financial Officer.

Read more

Former Bayer and Pharmacia Senior Executive Rolf A. Classon joins the Sequana Medical AG Board as Chairman

4 July 2016

Zurich, SWITZERLAND – 01 July 2016 – Sequana Medical AG, a privately held medical device company focused on the development and commercialization of innovative, implantable pump systems to manage fluid build-up in patients with liver disease, congestive heart failure and certain cancers, announced today that Rolf A. Classon, former top executive of Bayer AG and Pharmacia AB, has been appointed Chairman of the Board of Directors.

Read more

Sequana Medical AG raises CHF 9 million (USD 9.3M) in a Series C Extension

23 October 2015

Transaction Includes New Investors Salus Partners and Quest for Growth

Sequana Medical AG, a privately held medical device company focused on the development and commercialization of innovative implantable pump systems that manage excess fluid within the body, announced today that it has raised CHF 9 million ($9.3 million) in a Series C extension round.  Existing investors including NeoMed Management AS, VI Partners AG, Biomed Invest AG, Capricorn Health-tech Fund, Entrepreneurs Fund and Life Science Partners participated for a total of CHF 5.3M, with a further CHF 3.7M raised from new investors including Salus Partners SA and Quest for Growth NV.  Sequana Medical will use these funds to expand current business for its proven fluid management systems through new indications in heart disease and to pursue U.S. marketing approvals.

Read more

Sequana Medical presented the alfapump® system at this year’s Viszeralmedizin Congress in Leipzig, Germany

20 October 2015

Sequana Medical was delighted to present the alfapump system for the third time at this year’s nationwide Viszeralmedizin Congress, organised by the DGVS (German Society for Gastroenterology, Digestive and Metabolic Diseases) and the DGAV (German Society for General and Visceral Surgery), held in Leipzig’s CCL Congress Centre.

Read more

Sequana Medical presents exciting clinical updates on the alfapump® System at this year’s International Liver Congress in Vienna.

13 April 2015

Sequana Medical is delighted to be attending this year’s International Liver Congress in Vienna to present alfapump with DirectLink Technology.

Read more

Sequana Medical appoints Medinistros SAS as distributor for the alfapump® system in Colombia

27 March 2015

Sequana Medical is pleased to announce the appointment of Medinistros SAS as exclusive distributor for the alfapump system in Colombia.

Read more

Sequana Medical supports Bristol hepatologist Dr Anne McCune’s Sahara Challenge in aid of the British Liver Trust

10 March 2015

Sequana Medical is proud to support Dr Anne McCune in her brave trek across the Sahara in aid of the British Liver Trust.

Read more

Sequana Medical’s new alfapump® with DirectLink Technology improves the care of patients with challenging refractory ascites

1 December 2014

Technological advances in Sequana Medical’s alfapump system will allow patients and their doctors to better manage the distressing symptoms of refractory ascites. With enhanced communications enabled by the new DirectLink Technology, clinicians will now be able to monitor the alfapump remotely.

Read more

Financial Times reports that Sequana Medical’s raises $26 million in Series C financing round

28 April 2014

The Financial Times, one of the world’s leading business news organisations, reported today that Sequana Medical has raised $26 million in a Series C financing round.

Read more